Contineum Therapeutics, Inc. Class A Common Stock ( CTNM) - Stock Earnings
CTNM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -12.8 million USD | — USD |
| 2025Q4 | -15.2 million USD | — USD |
| 2026Q1 | -14.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CTNM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 22.7 million USD | 50.0 million USD |
| 2024 | -42.3 million USD | — USD |
| 2025 | -60.0 million USD | — USD |
| 2026 Est. | — | — |
CTNM
Price: $12.42
52 week price:
Earnings Per Share: -1.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 429.6 million